Pulmonary disease from biological agents: Anthrax, plague, Q fever, and tularemia

Critical Care Clinics

Volumn 21, Issue 4, 2005, Pages 747-763

  Daya, Mohamud ^a   Nakamura, Yoko ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; OFLOXACIN; PEFLOXACIN; PENICILLIN G; Q FEVER VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE; VACCINE;

ANTHRAX; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; CLINICAL FEATURE; COXIELLA BURNETII; DRUG EFFICACY; EPIDEMIC; FRANCISELLA TULARENSIS; HUMAN; INFLUENZA; LUNG DISEASE; MICROBIOLOGY; NONHUMAN; PATHOGENESIS; PLAGUE; PLEURA EFFUSION; PRIORITY JOURNAL; Q FEVER; REVIEW; TULAREMIA; VIRUS PNEUMONIA; YERSINIA PESTIS;

ANTHRAX; BIOTERRORISM; HUMANS; LUNG DISEASES; PLAGUE; Q FEVER; TULAREMIA;

EID: 24944514359     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2005.06.009     Document Type: Review

References (47)

1. L.D. Rotz, A.S. Khan, and S.R. Lillibridge Public health assessment of potential biological terrorism agents Emerg Infect Dis 8 2002 225 230
2. M.K. Jacobs The history of biologic warfare and bioterrorism Dermatol Clin 22 2004 231 246
3. A. Bryskier Bacillus anthracis and antibacterial agents Clin Microbiol Infect 8 2002 467 478
4. F.A. Abramova, L.M. Grinberg, and O.V. Yampolskaya Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979 Proc Natl Acad Sci USA 90 1993 2291 2294
5. K. Alibek, and S. Handleman Biohazard: the chilling true story of the largest covert biological weapons program in the world 1999 Random House New York
6. T.V. Inglesby, T. O'Toole, and D.A. Henderson Anthrax as a biological weapon, 2002: updated recommendations for management JAMA 287 2002 2236 2252
7. Centers for Disease Control and Prevention Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001 MMWR 50 2001 909 919
8. M. Mourez, D.B. Lacy, and K. Cunningham 2001: a year of major advances in anthrax toxin research Trends Microbiol 10 2002 287 293
9. T. Fukao Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity Lancet Infect Dis 4 2004 166 170
10. P.S. Brachman Inhalation anthrax Ann NY Acad Sci 353 1980 83 93
11. T.A. Mayer, S. Bersoff-Matcha, and C. Murphy Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients JAMA 286 2001 2549 2553
12. J.A. Jernigan, D.S. Stephens, and D.A. Ashford Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States Emerg Infect Dis 7 2001 933 944
13. M.J. Kuehnert, T.J. Doyle, and H.A. Hill Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses Clin Infect Dis 36 2003 328 336
14. D.N. Kyriacou, A.C. Stein, and P.R. Yarnold Clinical predictors of bioterrorism-related inhalational anthrax Lancet 364 2004 449 452
15. B.A. Cunha Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room Clin Microbiol Infect 8 2002 489 503
16. D.M. Bell, P.E. Kozarsky, and D.S. Stephens Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax Emerg Infect Dis 8 2002 222 225
17. R.D. Perry, and J.D. Fetherston Yersinia pestis - etiologic agent of plague Clin Microbiol Rev 10 1997 35 66
18. C.G. Cobbs, and D.H. Chansolme Plague Dermatol Clin 22 2004 303 312
19. M. Ratsitorahina, S. Chanteau, and L. Rahalison Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar Lancet 355 2000 111 113
20. K. Meyer Pneumonic plague Bacteriol Rev 25 1961 249 261
21. T.V. Inglesby, D.T. Dennis, and D.A. Henderson Plague as a biological weapon: medical and public health management JAMA 283 2000 2281 2290
22. D.T. Dennis, and F.A. Meier Plague C.R. Horsburgh Jr A.M. Nelson Pathology of emerging infections 1997 American Society for Microbiology Washington (DC) 21 47
23. S. Chanteau, L. Rahalison, and L. Ralafiarisoa Development and testing of a rapid diagnostic test for bubonic and pneumonic plague Lancet 361 2003 211 216
24. D.T. Dennis, and M.C. Chu A major new test for plague Lancet 361 2003 191 192
25. M. Galimand, A. Guiyoule, and G. Gerbaud Multidrug resistance in Yersinia pestis mediated by a transferable plasmid N Engl J Med 337 1997 677 680
26. T.V. Inglesby, D.A. Henderson, and T. O'Toole Safety precautions to limit exposure from plague-infected patients JAMA 284 2000 1648 1649
27. E.H. Derrick Q fever, a new entity: clinical features, diagnosis and laboratory investigation Med J Aust 2 1937 281 299
28. M. Maurin, and D. Raoult Q Fever Clin Microbiol Rev 12 1999 518 533
29. T.J. Marrie Coxiella burnetii pneumonia Eur Respir J 2 2003 713 719
30. R. Seshadri, I.T. Paulsen, and J.A. Eisen Complete genome sequence of the Q-fever pathogen Coxiella burnetii Proc Natl Acad Sci USA 100 2003 5455 5460
31. M.G. Madariaga, K. Rezai, and G.M. Trenholme Q fever: a biological weapon in your backyard Lancet Infect Dis 2 2003 709 721
32. S.J. Winner, R.P. Eglin, and V.I. Moore An outbreak of Q fever affecting postal workers in Oxfordshire J Infect 14 1987 255 261
33. S.J. Cutler, G.A. Paiba, and J. Howells Q fever - a forgotten disease Lancet Infect Dis 2 2002 717 718
34. D. Raoult, H. Tissot-Dupont, and C. Foucault Q fever 1985-1998: clinical and epidemiological features of 1,383 infections Medicine 79 2000 109 123
35. A. Gikas, D. Kofteridis, and D. Bouros Q fever pneumonia: appearance on chest radiographs Radiology 210 1999 339 343
36. A.E. Voloudaki, D.P. Kofteridis, and I.N. Tritou Q fever pneumonia: CT findings Radiology 215 2000 800 883
37. S.D. Cronquist Tularemia: the disease and the weapon Dermatol Clin 22 2004 313 320
38. D.T. Dennis, T.V. Inglesby, and D.A. Henderson Tularemia as a biological weapon: medical and public health management JAMA 285 2001 2763 2773
39. P.C. Oyston, A. Sjostedt, and R.W. Titball Tularemia: bioterrorism defense renews interest in Francisella tularensis Nat Rev Microbiol 2 2004 967 978
40. E. Choi Tularemia and Q fever Med Clin North Am 86 2002 393 416
41. R. Hornick Tularemia revisited N Engl J Med 345 2001 1637 1639
42. K.A. Feldman, R.E. Enscore, and S.L. Lathrop An outbreak of primary pneumonic tularemia on Martha's Vineyard N Engl J Med 345 2001 1601 1606
43. E. Croddy, and S. Krcalova Tularemia, biological warfare, and the battle for Stalingrad (1942-1943) Mil Med 166 2001 837 838
44. A. Tarnvik, and L. Berglund Tularemia Eur Respir J 21 2003 361 373
45. D.S. Shapiro, and E.J. Mark Case 14-2000. A 60-year-old farm worker with bilateral pneumonia N Engl J Med 342 2000 1430 1438
46. S.A. Rubin Radiographic spectrum of pleuropulmonary tularemia AJR Am J Roentgenol 131 1978 277 281
47. L.D. Rotz, and J.M. Hughes Advances in detecting and responding to threats from bioterrorism and emerging infectious disease Nat Med 10 2004 S130 S136